Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Eliezer M. Van Allen(Dana-Farber Cancer Institute), Levi A. Garraway(Broad Institute), Bastian Schilling(Goethe University Frankfurt), Ralf Gutzmer(University Hospitals of the Ruhr-University of Bochum), Uwe Hillen(University of Duisburg-Essen), Diana Miao(Broad Institute), Dirk Schadendorf(National Center for Tumor Diseases), Peter Mohr(Elbe Kliniken Stade-Buxtehude), Catherine J. Wu(Dana-Farber Cancer Institute), Katharina C. Kaehler(Christian-Albrechts-Universität zu Kiel), Antje Sucker(German Cancer Research Center), Stacey Gabriel(Broad Institute), Lisa Zimmer(The University of Sydney), Jessica C. Hassel(German Cancer Research Center), Carmen Loquai(Johannes Gutenberg University Mainz), Sachet A. Shukla(The University of Texas MD Anderson Cancer Center), Christian U. Blank(The Netherlands Cancer Institute), Reinhard Dummer(University Hospital of Zurich), Benjamin Weide(University Children's Hospital Tübingen), Jochen Utikal(German Cancer Research Center), Marnix H. Geukes Foppen(The Netherlands Cancer Institute), Simone M. Goldinger(Melanoma Institute Australia)
Cited by 2,998
Related Papers
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
The Structure of Haplotype Blocks in the Human Genome
|Science|2002|5.9k